fda glp 1 Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss The New York Times spotlighted

Future research should prioritize longitudinal and mechanistic studies to clarify causality, identify sensitive developmental windows, and determine whether dietary modification can be leveraged as a preventive or adjunct therapeutic approach

Jan 26 2024;16(3)doi:10.3390/nu16030370

Researchers use this combination to investigate peptide-receptor interactions, neuroendocrine signaling pathways, and cellular communication mechanisms in controlled laboratory models

ALMA enabled us to make a three-dimensional map of the distribution of ammonia gas below the clouds

Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors